Skip to the main content

Review article

APPLICATION OF OMALIZUMAB IN CHRONIC SPONTANEOUS URTICARIA/ANGIOEDEMA: RECOMMENDATIONS, EXPERIENCE AND PERCEPTIONS

LIBORIJA LUGOVIĆ-MIHIĆ orcid id orcid.org/0000-0001-7494-5742 ; Sestre milosrdnice University Hospital Centre, Department of Dermatovenereology, Zagreb, and University of Zagreb, School of Dental Medicine, Zagreb, Croatia
IVA FERČEK ; Sestre milosrdnice University Hospital Centre, Department of Dermatovenereology, Zagreb, Croatia
IVA BUKVIĆ ; Sestre milosrdnice University Hospital Centre, Department of Dermatovenereology, Zagreb, and University of Zagreb, School of Dental Medicine, Zagreb, Croatia
TOMISLAV DUVANČIĆ orcid id orcid.org/0000-0002-6121-3232 ; Sestre milosrdnice University Hospital Centre, Department of Dermatovenereology, Zagreb, and University of Zagreb, School of Dental Medicine, Zagreb, Croatia


Full text: croatian pdf 127 Kb

page 495-501

downloads: 2.345

cite


Abstract

Patients with chronic urticaria (CU), with hives for more than 6 weeks, often experience problems with the unpredictability of hives, social isolation, decreased sleep quality due to associated itchiness and fatigue. In almost half of patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) the cause of the condition was undetermined but 30%-50% of patients were found to produce IgG autoantibodies directed against IgE or its high affinity receptors (Fc

Keywords

chronic urticaria; therapy; omalizumab; chronic idiopathic/spontaneous urticaria

Hrčak ID:

216547

URI

https://hrcak.srce.hr/216547

Publication date:

30.1.2019.

Article data in other languages: croatian

Visits: 3.250 *